Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma

Journal of Cellular Physiology

Volumn 225, Issue 2, 2010, Pages 601-611

  Diaz Romero, Jose ^a   Romeo, Salvatore ^b,c   Bovée, Judith V M G ^b   Hogendoorn, Pancras C W ^b   Heini, Paul F ^a,d   Mainil Varlet, Pierre ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TREVISO REGIONAL HOSPITAL   (Italy)

^d Orthopaedic Hospital Sonnenhof   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CD22 ANTIGEN; CELL SURFACE MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BIOTRANSFORMATION; CARTILAGE CELL; CELL LINEAGE; CELL TYPE; CHONDROSARCOMA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; EPITHELIUM CELL; EVALUATION; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFORMATION PROCESSING; MALE; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; ALGORITHM; BONE TUMOR; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; ALGORITHMS; BONE NEOPLASMS; CELL LINE, TUMOR; CHONDROCYTES; CHONDROSARCOMA; CLUSTER ANALYSIS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956531072     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22245     Document Type: Article

References (58)

1. Aigner T. 2002. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton-biochemistry and cell biology of chondrosarcoma and its variants. Virchows Arch 441:219-230.
2. Aigner T, Muller S, Neureiter D, Illstrup DM, Kirchner T, Bjornsson J. 2002. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas. Cancer 94:2273-2281. (Pubitemid 34411987)
3. Anichini A, Mortarini R, Nonaka D, Molla A, Vegetti C, Montaldi E, Wang X, Ferrone S. 2006. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients. Cancer Res 66:6405-6411.
4. Azuaje F, Bolshakova N. 2002. Clustering genomic expression data: Design and evaluation principles. In: Berrar D, Dubitzky W, Granzow M, editors. Understanding and using microarray analysis techniques: A practical guide. London: Kluwer Academic Publishers. pp. 230-245.
5. Belacel N, Wang Q, Cuperlovic-Culf M. 2006. Clustering methods for microarray gene expression data. Omics 10:507-531. (Pubitemid 46174583)
6. Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn P, Bovee J, Richter W. 2008. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma. J Pathol 216:158-166.
7. Bovee JV, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC. 2005. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol 6:599-607.
8. Chattopadhyay PK, Hogerkorp CM, Roederer M. 2008. A chromatic explosion: The development and future of multiparameter flow cytometry. Immunology 125:441-449.
9. de Souto MC, Costa IG, de Araujo DS, Ludermir TB, Schliep A. 2008. Clustering cancer gene expression data: A comparative study. BMC Bioinformatics 9:497.
10. D'Haeseleer P. 2005. How does gene expression clustering work? Nat Biotechnol 23:1499-1501.
11. Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T, Mainil-Varlet P. 2005. Immunophenotypic analysis of human articular chondrocytes: Changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 202:731-742. (Pubitemid 40175849)
12. Diaz-Romero J, Nesic D, Grogan SP, Heini P, Mainil-Varlet P. 2008. Immunophenotypic changes of human articular chondrocytes during monolayer culture reflect bona fide dedifferentiation rather than amplification of progenitor cells. J Cell Physiol 214:75-83. (Pubitemid 350220061)
13. Dupuy A, Simon RM. 2007. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. JNatl Cancer Inst 99:147-157.
14. Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovee JV, Hogendoorn PC. 2009. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol 33:50-57.
15. Ertel A, Verghese A, Byers SW, Ochs M, Tozeren A. 2006. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer 5:55. (Pubitemid 44742653)
16. Gebauer M, Saas J, Sohler F, Haag J, Soder S, Pieper M, Bartnik E, Beninga J, Zimmer R, Aigner T. 2005. Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta. Osteoarthritis Cartilage 13:697-708. (Pubitemid 41025123)
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5:R80.
18. Gey GO, Coffman WD, Kubicek MT. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264-265.
19. Gil-Benso R, Lopez-Gines C, Lopez-Guerrero JA, Carda C, Callaghan RC, Navarro S, Ferrer J, Pellin A, Llombart-Bosch A. 2003. Establishment and characterization of a continuous human chondrosarcoma cell line, ch-2879: Comparative histologic and genetic studies with its tumor of origin. Lab Invest 83:877-887. (Pubitemid 36723697)
20. Gong Y, Yao E, Shen R, Goel A, Arcila M, Teruya-Feldstein J, Zakowski MF, Frankel S, Peifer M, Thomas RK, Ladanyi M, Pao W. 2009. High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). PLoS ONE 4:e7273.
21. Habib LK, Finn WG.2006. Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia. Cytometry B Clin Cytom 70:124-135.
22. Handl J, Knowles J, Kell DB. 2005. Computational cluster validation in post-genomic data analysis. Bioinformatics 21:3201-3212. (Pubitemid 41418432)
23. Ho L, Stojanovski A, Whetstone H, Wei QX, Mau E, Wunder JS, Alman B. 2009. Gli2 and p53 cooperate to regulate IGFBP-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. Cancer Cell 16:126-136.
24. Holgersson M. 1978. Limited value of cophenetic correlation as a clustering criterion. Pattern Recognit 10:287-295. (Pubitemid 9036860)
25. Hubert L, Arabie P. 1985. Comparing partitions. J Classif 2:193-218.
26. Jakob M, Demarteau O, Schafer D, Hintermann B, Dick W, Heberer M, Martin I. 2001. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 81:368-377. (Pubitemid 32298268)
27. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. 1979. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23. (Pubitemid 9239413)
28. Kaufman L, Rousseeuw PJ. 2005. Finding groups in data: An introduction to cluster analysis. Hoboken, NJ: Wiley. xiv, 342 pp.
29. Kitsos CM, Bhamidipati P, Melnikova I, Cash EP, McNulty C, Furman J, Cima MJ, Levinson D. 2007. Combination of automated high throughput platforms, flow cytometry, and hierarchical clustering to detect cell state. Cytometry A 71:16-27.
30. Kunisada T, Miyazaki M, Mihara K, Gao C, Kawai A, Inoue H, Namba M. 1998. A new human chondrosarcoma cell line (OUMS-27) that maintains chondrocytic differentiation. Int J Cancer 77:854-859. (Pubitemid 28378133)
31. Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND. 1976. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36:4562-4569.
32. Li T, Zhang C, Ogihara M. 2004. A comparative study of feature selection and multiclass classification methods for tissue classification based on gene expression. Bioinformatics 20:2429-2437. (Pubitemid 39429915)
33. Li R, Pourpak A, Morris SW. 2009. Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem 52:4981-5004.
34. Lizard G. 2007. Flow cytometry analyses and bioinformatics: Interest in new softwares to optimize novel technologies and to favor the emergence of innovative concepts in cell research. Cytometry A 71:646-647.
35. Lugli E, Pinti M, Nasi M, Troiano L, Ferraresi R, Mussi C, Salvioli G, Patsekin V, Robinson JP, Durante C, Cocchi M, Cossarizza A. 2007. Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry A 71:334-344.
36. Mankin HJ, Cantley KP, Lippiello L, Schiller AL, Campbell CJ. 1980. The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses. J Bone Joint Surg Am 62:160-176.
37. Marchette DJ, Solka JL. 2003. Using data images for outlier detection. Comput Stat Data Anal 43:541-552.
38. Maynadie M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Verge V, Bissieres P, Raphael M, Bene MC, Feuillard J. 2002. Immunophenotypic clustering of myelodysplastic syndromes. Blood 100:2349-2356.
39. Meunier B, Dumas E, Piec I, Bechet D, Hebraud M, Hocquette JF. 2007. Assessment of hierarchical clustering methodologies for proteomic data mining. J Proteome Res 6:358-366. (Pubitemid 46173687)
40. Morgan BJT, Ray APG. 1995. Nonuniqueness and inversions in cluster-analysis. J R Stat Soc Ser C Appl Stat 44:117-134.
41. Ouyang P. 1998. An in vitro model to study mesenchymal-epithelial transformation. Biochem Biophys Res Commun 246:771-776. (Pubitemid 28420933)
42. Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF. 1977. Tumor antigen and human chorionic gonadotropin in CaSki cells: A new epidermoid cervical cancer cell line. Science 196:1456-1458.
43. Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J, Wigler M. 1981. Human-tumor-derived cell lines contain common and different transforming genes. Cell 27:467-476.
44. Petrausch U, Haley D, Miller W, Floyd K, Urba WJ, Walker E. 2006. Polychromatic flow cytometry:Arapid method for the reduction and analysis of complex multiparameter data. Cytometry A 69:1162-1173.
45. Rawstron AC, de Tute R, Jack AS, Hillmen P. 2006. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: Identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Leukemia 20:2102-2110. (Pubitemid 44782835)
46. Sandberg AA. 2004. Genetics of chondrosarcoma and related tumors. Curr Opin Oncol 16:342-354.
47. Sardiu ME, Florens L, Washburn MP. 2009. Evaluation of clustering algorithms for protein complex and protein interaction network assembly. J Proteome Res 8:2944-2952.
48. Soderstrom M, Bohling T, Ekfors T, Nelimarkka L, Aro HT, Vuorio E. 2002. Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer 100:144-151. (Pubitemid 34666187)
49. Sokal RR, Rohlf FJ. 1962. The comparison of dendrograms by objective methods. Taxon 11:33-40.
50. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423.
51. Steinbrich-Zollner M, Grun JR, Kaiser T, Biesen R, Raba K, Wu P, Thiel A, Rudwaleit M, Sieper J, Burmester GR, Radbruch A, Grutzkau A. 2008. From transcriptome to cytome: Integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases. Cytometry A 73:333-340.
52. Szuhai K, Tanke HJ. 2006. COBRA: Combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping. Nat Protoc 1:264-275.
53. van Staveren WC, Solis DY, Hebrant A, Detours V, Dumont JE, Maenhaut C. 2009. Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim Biophys Acta 1795:92-103.
54. Verhaak RG, Staal FJ, Valk PJ, Lowenberg B, Reinders MJ, de Ridder D. 2006. The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies. BMC Bioinformatics 7:105. (Pubitemid 43933059)
55. Yang X, Pursell B, Lu S, Chang TK, Mercurio AM. 2009. Regulation of {beta}4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J Cell Sci 122:2473-2480.
56. Yeung KY, Medvedovic M, Bumgarner RE. 2003. Clustering gene-expression data with repeated measurements. Genome Biol 4:R34.
57. Zha J, O'Brien C, Savage H, Huw LY, Zhong F, Berry L, Lewis Phillips GD, Luis E, Cavet G, Hu X, Amler LC, Lackner MR. 2009. Molecular predictors of response to a humanized anti-insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer. Mol Cancer Ther 8:2110-2121.
58. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Bulian P, Benedetti D, Rupolo M, Del Poeta G, Campanini R, Gattei V. 2006. Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: From the signature of specific disease subsets to the identification of markers with prognostic relevance. J Transl Med 4:11.